This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Allstate (ALL) Announces December and Q4 Cat Loss Estimates
by Zacks Equity Research
Allstate (ALL) discloses catastrophe loss estimates for December and the fourth quarter of 2021. However, ALL remains well-equipped to counter them with reinsurance programs.
Travelers (TRV) Q4 Earnings, Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Travelers (TRV) Q4 results reflect higher net investment income and a higher underlying underwriting gain, partially offset by lower net favorable prior year reserve development.
The Zacks Analyst Blog Highlights: Pacira BioSciences, D.R. Horton ArcBest, Axis Capital Holdings and CF Industries
by Zacks Equity Research
Pacira BioSciences, D.R. Horton ArcBest, Axis Capital Holdings and CF Industries are highlighted in this Analyst Blog Article.
Axis Capital (AXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Axis Capital (AXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are These Finance Stocks Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Reasons to Bet On These 5 Buy Ranked Stocks
by Sejuti Banerjea
PCRX, DHI, ARCB, AXS and CF balance value and growth and are therefore worth picking up.
New Strong Buy Stocks for January 18th
by Zacks Equity Research
KBH, BAX, F, EGO, and AXS have been added to the Zacks Rank #1 (Strong Buy) List on January 18, 2022.
Can Travelers (TRV) Retain Its Surprise Streak in Q4 Earnings?
by Zacks Equity Research
Travelers' (TRV) fourth-quarter results are likely to reflect strength across its segments.
Best Momentum Stocks to Buy for January 17th
by Zacks Equity Research
F, GT, and AXS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 17, 2022
New Strong Buy Stocks for January 17th
by Zacks Equity Research
AXS, BAX, F, UNFI, and BRDG have been added to the Zacks Rank #1 (Strong Buy) List on January 17, 2022.
Best Income Stocks to Buy for January 17th
by Zacks Equity Research
BRDG, AXS, and F made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 17, 2022
Should You Retain Axis Capital (AXS) Stock in Your Portfolio?
by Zacks Equity Research
AXIS Capital (AXS) is poised to benefit from positive returns from alternative assets, new business growth and prudent capital deployment.
AXS vs. BRK.B: Which Stock Is the Better Value Option?
by Zacks Equity Research
AXS vs. BRK.B: Which Stock Is the Better Value Option?
Progressive (PGR) November Earnings Decline, Revenues Up Y/Y
by Zacks Equity Research
Progressive's (PGR) November results reflect solid policies in force and higher net premiums earned, offset by a rise in expenses and lower net investment income.
Should Value Investors Buy Axis Capital Holdings (AXS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
American Financial's (AFG) Board Okays $2 Special Dividend
by Zacks Equity Research
The board of directors of American Financial (AFG) approves a special cash dividend of $2.00 per share, banking on its solid financial position, which reflects its commitment to boost shareholders' value.
Erie Indemnity (ERIE) Hikes Dividend to Share More Profits
by Zacks Equity Research
Erie Indemnity's (ERIE) recent dividend hike and special dividend reflect its intention to enhance shareholders' value supported by its strong financial position.
Here's Why Hold is an Apt Strategy for AXIS Capital (AXS)
by Zacks Equity Research
AXIS Capital (AXS) continues to build on its Specialty Insurance, Reinsurance plus Accident and Health portfolio coupled with an improved portfolio mix.
The Hanover Insurance (THG) Ups Dividend to Share More Profit
by Zacks Equity Research
The Hanover Insurance Group's (THG) recent dividend hike reflects its intention to enhance shareholders' value supported by a strong financial position.
AXIS Capital (AXS) Okays Dividend Increase, Share Buyback
by Zacks Equity Research
AXIS Capital's (AXS) recent dividend hike and share buyback approval reflects its intention to enhance shareholders' value supported by its strong financial position.
AXIS Capital (AXS) Q3 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
AXIS Capital's (AXS) Q3 results reflect higher gross premiums written as well as an increase in net investment income and lower expenses.
Palomar (PLMR) Announces Estimates for Q3 Catastrophe Loss
by Zacks Equity Research
Palomar (PLMR) estimates third-quarter pre-tax cat loss from Hurricanes Ida and Nicholas to be about $14.5 million to $15.5 million.
AXIS Capital (AXS) Estimates Q3 Catastrophe Loss of $250M
by Zacks Equity Research
AXIS Capital (AXS) third-quarter estimated cat loss of $250 million primarily takes into account losses from Hurricane Ida, European floods and other catastrophe and weather-related events.
AXIS Capital (AXS) Banks on Premiums Amid Cost Concerns
by Zacks Equity Research
AXIS Capital (AXS) is well-poised to benefit from new business opportunities, premium adjustments and effective capital deployment.
American Financial (AFG) Board Approves Special Dividend
by Zacks Equity Research
American Financial's (AFG) special cash dividend of $4.00 per share marks the company's capital management strategy enhancing shareholders' value.